e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Asthma: risk factors and effect of anti-IgE
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-IgE antibodies inhibit the expression of amphiregulin in mast cells and suppress remodeling
M. Mizuguchi, M. Wada, K. Kikuchi, K. Akasaka, K. Kohyama, N. Fueki, H. Sagara (Koshigaya, Japan)
Source:
Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Session:
Asthma: risk factors and effect of anti-IgE
Session type:
Poster Discussion
Number:
241
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mizuguchi, M. Wada, K. Kikuchi, K. Akasaka, K. Kohyama, N. Fueki, H. Sagara (Koshigaya, Japan). Anti-IgE antibodies inhibit the expression of amphiregulin in mast cells and suppress remodeling. Eur Respir J 2012; 40: Suppl. 56, 241
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
TNF-α and TGF-β1 synergistically upregulate the expression of endothelin-1 in airway epithelial cell
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Modulation of FceRI expression on cultured mast cells by IgE and anti-IgE
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
Glucocorticoids enhance CCL20 release in bronchial epithelial cells in a metalloprotease-dependent manner
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
PAR-2 mediated interactions between mast cells and fibroblasts cause a switch in fibroblast morphology and cytokine profile
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Activation of PAR-2 enhances ICAM-1 expression and IL-8 release in airway epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 571s
Year: 2002
Rolipram inhibits eotaxin-3 releasing in human epithelial cells BEAS-2B stimulated with Th2 cytokines
Source: Eur Respir J 2007; 30: Suppl. 51, 219s
Year: 2007
Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Expression of amphiregulin regulates airway remodeling
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
Theophylline at the therapeutic concentrations abrogate decreased smad7 expression in cultured smooth muscle cells stimulated with LTD4 and EGF
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005
Interleukin-8 stimulates human airway epithelial cell proliferation through EGFR transactivation
Source: Eur Respir J 2003; 22: Suppl. 45, 561s
Year: 2003
Regulation of
Mycoplasma pneumoniae
lysate-induced IL-8 expression in human airway epithelial cells
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
Statins inhibit human lung fibroblast production and activation of MMPs
Source: Eur Respir J 2007; 30: Suppl. 51, 692s
Year: 2007
Regulation of surface expression of high-affinity IgE receptor and cell survival in human cultured basophils by IgE and interleukin-3
Source: Eur Respir J 2002; 20: Suppl. 38, 208s
Year: 2002
Melatonin promoted the chemotaxin expression in human lung epithelial cell stimulated with TNF-α
Source: Eur Respir J 2003; 22: Suppl. 45, 560s
Year: 2003
Lysophospholipids stimulate proliferation of rat primary airway fibroblasts
Source: Eur Respir J 2003; 22: Suppl. 45, 452s
Year: 2003
Mast cell tryptase induce alarmin release and secretion of pro-inflammatory cytokines from bronchial epithelial cells
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept